Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited)

v3.7.0.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - 3 months ended Mar. 31, 2017 - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Deficit Accumulated [Member]
Total
Beginning balance, shares at Dec. 31, 2016 199,045,026      
Beginning balance, value at Dec. 31, 2016 $ 199,045 $ 103,716,955 $ (105,274,000) $ (1,358,000)
Common stock issued on conversion of notes payable, shares issued 2,391,400      
Common stock issued on conversion of notes payable, value $ 2,391 117,609   120,000
Fair value of warrants and beneficial conversion feature of issued convertible notes   201,000   201,000
Fair value of options and warrants issued as compensation   235,000   235,000
Net loss     (1,484,000) (1,484,000)
Ending balance, shares at Mar. 31, 2017 201,436,426      
Ending balance, value at Mar. 31, 2017 $ 201,436 $ 104,270,256 $ (106,758,000) $ (2,286,000)